|

Cobicistat Clinical Trials

4 actively recruiting trials across 1 location

Also known as: Tybost

Pipeline

Phase 2: 1Phase 4: 2Phase 1/2: 1

Top Sponsors

  • Syndax Pharmaceuticals1
  • Stichting Hemato-Oncologie voor Volwassenen Nederland1
  • Radboud University Medical Center1
  • Maastricht University Medical Center1

Indications

  • Cancer4
  • Mixed Lineage Acute Leukemia1
  • AML, Adult1
  • Mixed Phenotype Acute Leukemia1
  • Acute Leukemia of Ambiguous Lineage1

Other3 trials

A Trial to Assess Cobicistat Boosted Venetoclax in Combination With Azacitidine in Adult Patients With Newly Diagnosed AML
Phase 2
Improving Osimertinib Exposure and Cost-effectiveness Using Pharmacokinetic Boosting With Cobicistat
Phase 4
Pharmacokinetic Boosting of Olaparib to Improve Exposure, Tolerance and Cost-effectiveness
Phase 4

Duarte, California1 trial

A Study of Revumenib in R/R Leukemias Including Those With an MLL/KMT2A Gene Rearrangement or NPM1 Mutation

City of Hope Comprehensive Cancer Center

Phase 1/2

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.